Clinical Trial Update: Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether vitamin E can prevent chemotherapy-induced peripheral neuropathy in cancer patients; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08